Arvee Laboratories (India) Ltd
NSE:ARVEE
Arvee Laboratories (India) Ltd
Arvee Laboratories (India) Ltd. provides chemical products, which includes polymer modifiers, contrast media and drug intermediates. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2018-02-22. The firm is primarily engaged in the manufacturing of Polymer Modifiers, Contrast Media Intermediates and Drug Intermediates. The Company’s Polymer Modifiers include 5-Sulfoisophthalic Acid Mono Sodium Salt, Dimethyl 5-Sodiosulfoisophthalate and 5-Sulfoisophthalic Acid Mono Lithium Salt. Its Contrast Media Intermediates include 5-Nitroisophthalic acid, 5-Aminoisophthalic acid, Dimethyl 5-Nitroisophthalate, 5-Hydroxyisophthalic acid, Monomethyl 5-Nitroisophthalate, 3,5-Diamino Benzoic Acid, Dimethyl 5-Aminoisophthalate and 3,5-Dinitrobenzoic acid. Its Drug Intermediates include 2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde, 4-Amino Pyridine and 2-Chloro-5-Nitrobenzoic Acid.
Arvee Laboratories (India) Ltd. provides chemical products, which includes polymer modifiers, contrast media and drug intermediates. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2018-02-22. The firm is primarily engaged in the manufacturing of Polymer Modifiers, Contrast Media Intermediates and Drug Intermediates. The Company’s Polymer Modifiers include 5-Sulfoisophthalic Acid Mono Sodium Salt, Dimethyl 5-Sodiosulfoisophthalate and 5-Sulfoisophthalic Acid Mono Lithium Salt. Its Contrast Media Intermediates include 5-Nitroisophthalic acid, 5-Aminoisophthalic acid, Dimethyl 5-Nitroisophthalate, 5-Hydroxyisophthalic acid, Monomethyl 5-Nitroisophthalate, 3,5-Diamino Benzoic Acid, Dimethyl 5-Aminoisophthalate and 3,5-Dinitrobenzoic acid. Its Drug Intermediates include 2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde, 4-Amino Pyridine and 2-Chloro-5-Nitrobenzoic Acid.
